Viewing nowCombinationPosia Tablets 10/100 Milligrams (Dapagliflozin, Sitagliptin)
Dapagliflozin Propanediol Hydrate 12.3mg · Sitagliptin Phosphate Hydrate 128.5mg
Tablet · Prescription medication · Combination
Jungheon Pharmaceutical Co., Ltd.

MFDS item code 202300389 · Approved 2023.01.30 · Insurance code 053301140
Improvement of glycemic control in type 2 diabetes mellitus
This medication is used to assist in blood sugar control in patients with type 2 diabetes by using sitagliptin and dapagliflozin together. It enhances blood sugar control effectiveness through conjunction with meal and exercise therapy, which is helpful to patients who have difficulty managing their blood sugar levels. As a result, it effectively improves blood sugar levels and supports diabetes treatment.
This drug may be administered as one tablet once daily, with or without food, to patients taking sitagliptin 100 mg and dapagliflozin 10 mg. The tablet should be swallowed whole. The efficacy and safety of this drug depend on renal function. It is recommended that renal function be assessed before treatment with this drug and periodically thereafter. - No dose adjustment is required when the estimated glomerular filtration rate (eGFR) is 45 mL/min/1.73m2 or higher. - Do not administer this drug when the estimated glomerular filtration rate (eGFR) is less than 45 mL/min/1.73 m2. No dose adjustment is required in patients with mild or moderate hepatic impairment. Use of this drug is not recommended in patients with severe hepatic impairment.
This medication may cause severe allergic reactions due to the sitagliptin component; therefore, if symptoms such as skin rash, difficulty breathing, or swelling of the face or neck occur after taking it, immediately discontinue use and consult a physician. Additionally, this medication may cause serious pancreatic inflammation known as pancreatitis during use, so if symptoms such as abdominal pain, vomiting, or nausea arise, promptly inform medical personnel. This medication should not be administered to patients with type 1 diabetes, diabetic ketoacidosis, or those undergoing dialysis. Use with caution in patients with reduced fluid volume or renal dysfunction, particularly in elderly patients or those on diuretics, who should be closely monitored for hypotension or dehydration symptoms. Dose adjustment may be required for patients with reduced kidney function, and regular kidney function tests should be conducted before and during treatment. There may be an increased risk of genital infections and urinary tract infections during use; thus, rapid treatment should be sought if infection symptoms arise. Moreover, caution is warranted for hypoglycemia risk when taken with other hypoglycemic agents such as insulin or sulfonylureas, and dosage adjustment of those medications may be necessary as needed. Pregnant or breastfeeding women are advised not to take this medication, and if pregnancy is confirmed, use should be immediately discontinued. This medication should not be used in patients under 18 years of age as safety and efficacy have not been established. In cases of overdose, as there are no specific antidotes, appropriate treatment according to symptoms should be sought, and hospital observation and treatment may be required if necessary. Lastly, caution is advised during driving or operating machinery as there may be risks of hypoglycemia during use of this medication.
Not everyone experiences these, and they can vary from person to person.
This medication may be sensitive to air and moisture and should be stored in a tightly closed container. It is important to maintain a storage temperature between 1 and 30 degrees Celsius (room temperature) to ensure the medication's effectiveness.
Beige oval film-coated tablet
30 tablets/PTP [10 tablets/PTP (Alu-Alu) x 3]
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowCombinationDapagliflozin Propanediol Hydrate 12.3mg · Sitagliptin Phosphate Hydrate 128.5mg
Tablet · Prescription medication · Combination
Jungheon Pharmaceutical Co., Ltd.
CombinationDapagliflozin Propanediol Hydrate 12.3mg · Sitagliptin Phosphate Hydrate 128.5mg
Tablet · Prescription medication · Combination
Donggu Bio Pharmaceutical Co., Ltd.
CombinationDapagliflozin Propanediol Hydrate 12.3mg · Sitagliptin Phosphate Hydrate 128.5mg
Tablet · Prescription medication · Combination
Daewoo Pharmaceutical Co., Ltd.
CombinationDapagliflozin Propanediol Hydrate 12.3mg · Sitagliptin Phosphate Hydrate 128.5mg
Tablet · Prescription medication · Combination
International Pharmaceutical Co., Ltd.
CombinationDapagliflozin Propanediol Hydrate 12.3mg · Sitagliptin Phosphate Hydrate 128.5mg
Tablet · Prescription medication · Combination
Shinpoong Pharmaceutical Co., Ltd.
CombinationDapagliflozin Propanediol Hydrate 12.3mg · Sitagliptin Phosphate Hydrate 128.5mg
Tablet · Prescription medication · Combination
IYON Pharmaceutical Co., Ltd.
CombinationDapagliflozin Propanediol Hydrate 12.3mg · Sitagliptin Phosphate Hydrate 128.5mg
Tablet · Prescription medication · Combination
Kujoo Pharmaceutical Co., Ltd.
Dapagliflozin Propanediol Hydrate 12.3mg · Sitagliptin Phosphate Hydrate 128.5mg
Tablet · Prescription medication · Combination
Ildong Pharmaceutical Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.